Latest Roswell Park Cancer Institute Stories
The NCCN Guidelines for Kidney Cancer have been updated to incorporate the recently approved therapy pazopanib as a treatment option for patients with advanced renal cell carcinoma.
Although colonoscopy remains the preferred colorectal cancer screening method, the recently updated NCCN Guidelines for Colorectal Cancer Screening have added annual immunohistochemical stool testing with or without a flexible sigmoidoscopy every five years as an alternate screening option for average risk individuals.
The National Comprehensive Cancer Network (NCCN) recently updated the NCCN Guidelines for Acute Myeloid Leukemia (AML), the most common acute leukemia affecting adults.
NCCN has added pralatrexate (Folotyn(TM), Allos Therapeutics, Inc.) to the NCCN Guidelines for Non-Hodgkin's Lymphomas as one of the options for second-line therapy for relapsed or refractory peripheral T-cell lymphoma.
CHICAGO, Oct. 1 /PRNewswire/ -- According to new research from the American College of Surgeons (ACoS), two-thirds of women (66 percent) did not know about accreditation of breast care centers, what it means, and why it is important.
NCCN is holding the NCCN Oncology Research Best Practices Conference(TM), an interactive forum to discuss the regulatory and operational aspects of research and help identify areas in the clinical trial process where improvements can be made.
PHOENIX, Aug. 14 /PRNewswire/ -- Arizona Oncology, the largest group of medical professionals in Arizona devoted exclusively to cancer care, began caring for patients at its new 6,600 square-foot radiation facility in Phoenix last week. Located at 1916 W.
The National Comprehensive Cancer Network (NCCN) recently updated the NCCN Guidelines for Prostate Cancer Early Detection incorporating the results of the recent ERSPC trial that assessed the benefit of PSA screening.
The National Comprehensive Cancer Network (NCCN) is developing a methodology for the evaluation and application of the Comparative Effectiveness of health care technologies in cancer care.
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.